{"id":"W3042003151","doi":"10.1111/bjd.19393","title":"Long‐term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3‐year results from two randomized phase III trials (CIMPASI‐1 and CIMPASI‐2)","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Psoriasis; Plaque psoriasis; Term (time); Randomized controlled trial; Internal medicine; Dermatology; Adalimumab; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008580426,0.001425966,0.002923739,0.0003980605,0.0005219424,0.001479413,0.0009058336,0.001885631,0.003441813],"category_scores_gemma":[0.0047592,0.0006107131,0.004645165,0.0005546451,0.0009804954,0.001038744,0.0005218466,0.00336723,0.0006448157],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00106889,"about_ca_system_score_gemma":0.00165175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001016788,"about_ca_topic_score_gemma":0.001885328,"domain_scores_codex":[0.9976331,0.001437583,0.0001907221,0.0002529043,0.0002195273,0.0002660847],"domain_scores_gemma":[0.9959734,0.001304077,0.001276466,0.000383843,0.0002628079,0.0007993586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9568787,0.007298842,0.002226207,0.0008182122,0.003492046,0.00004586466,0.0001000188,0.0006127229,0.002814022,0.0000620221,0.0009205923,0.02473069],"study_design_scores_gemma":[0.9145849,0.07301625,0.008542689,0.000082724,0.002184368,0.00004392839,0.00002292278,0.0002994121,0.0004970467,0.00009140083,0.0006123095,0.00002214253],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9701994,0.01950577,0.001485991,0.0009631137,0.0003506917,0.003633899,0.002262229,0.0001277188,0.001471267],"genre_scores_gemma":[0.9785317,0.008307138,0.001994612,0.0013592,0.0004378073,0.004615208,0.003183645,0.00004663683,0.00152411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008580426,"threshold_uncertainty_score":0.04537821,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04312098484127033,"score_gpt":0.3067506831711608,"score_spread":0.2636296983298905,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}